Accès gratuit
Pré-publication électronique
Dans une revue
Colon Rectum
Section Article de Référence / Standard reference article
DOI https://doi.org/10.3166/cer-2020-0146
Publié en ligne 29 juillet 2020
  • Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery, the clue to pelvic recurrence? Br J Surg 69:613–6 [CrossRef] [PubMed] [Google Scholar]
  • Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–46 [CrossRef] [PubMed] [Google Scholar]
  • Gérard JP, Conroy T, Bonnetain F, et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–5 [CrossRef] [PubMed] [Google Scholar]
  • Williams NS (2010) The rectal “no man’s land” and sphincter preservation during rectal excision. Br J Surg 97:1749–51 [CrossRef] [Google Scholar]
  • Targarona EM, Balague C, Pernas JC, et al (2008) Can we predict immediate outcome after laparoscopic rectal surgery? Multivariate analysis of clinical, anatomic, and pathologic features after 3-dimensional reconstruction of the pelvic anatomy. Ann Surg 247:642–9 [CrossRef] [Google Scholar]
  • Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–10 [CrossRef] [PubMed] [Google Scholar]
  • Lelong B, Meillat H, Zemmour C, et al (2017) Short- and midterm outcomes after endoscopic transanal or laparoscopic transabdominal total mesorectal excision for low rectal cancer: a single institutional case-control study. J Am Coll Surg 224:917–25 [CrossRef] [Google Scholar]
  • Fernández-Hevia M, Delgado S, Castells A, et al (2015) Transanal total mesorectal excision in rectal cancer short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261:221–7 [CrossRef] [PubMed] [Google Scholar]
  • Chen C, Lai Y, Jiang J, et al (2016) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation : a matched case – control study. Ann Surg Oncol 23:1169–76 [CrossRef] [Google Scholar]
  • Rasulov AO, Mamedli ZZ, Gordeyev SS, et al (2016) Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol 20:227–34 [CrossRef] [Google Scholar]
  • Perdawood SK, Thinggaard BS, Bjoern MX (2017) Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc 32:2312‒21 [CrossRef] [Google Scholar]
  • Aubert M, Mege D, Panis Y (2020) Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach - a meta-analysis. Surg Endosc (sous presse) [Google Scholar]
  • Larsen SG, Pfeffer F, Kørner H; Norwegian Colorectal Cancer Group (2019) Norwegian moratorium on transanal total mesorectal excision. Br J Surg 106:1120–1 [CrossRef] [Google Scholar]
  • Aubert M, Mege D, Panis Y (2019) Transanal total mesorectal excision for low and middle rectal cancer: time for audit? Tech Coloproctol 23:703–5 [CrossRef] [Google Scholar]
  • Burke JP, Martin-Perez B, Khan A, et al (2016) Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal Dis 18:570–7 [CrossRef] [Google Scholar]
  • Lacy AM, Tasende MM, Delgado S, et al (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221:415–23 [CrossRef] [Google Scholar]
  • Jeong SY, Park JW, Nam BH, et al (2014) Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomized controlled trial. Lancet Oncol 15:767–74 [CrossRef] [PubMed] [Google Scholar]
  • Fleshman J, Branda M, Sargent DJ, et al (2015) Effect of laparoscopic-assisted resection vs. open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOGZ6051 randomized clinical trial. JAMA 314:1346–55 [CrossRef] [PubMed] [Google Scholar]
  • Stevenson ARL, Solomon MJ, Lumley JW, et al (2015) Effect of laparoscopic-assisted resection vs. open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–63 [CrossRef] [PubMed] [Google Scholar]
  • Bjoern MX, Nielsen S, Perdawood SK (2019) Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg 23:1623–30 [CrossRef] [Google Scholar]
  • Penna M, Hompes R, Arnold S, et al (2018) Incidence and risk factors for anastomotic failure in 1,594 patients treated by transanal total mesorectal excision. Ann Surg 269:700–11 [CrossRef] [PubMed] [Google Scholar]
  • Detering R, Roodbeen SX, van Oostendorp SE, et al (2019) Three-year nationwide experience with transanal total mesorectal excision for rectal cancer in the Netherlands: a propensity scorematched comparison with conventional laparoscopic total mesorectal excision. J Am Coll Surg 228:235‒44 [CrossRef] [PubMed] [Google Scholar]
  • Atallah SB, DuBose AC, Burke JP, et al (2017) Uptake of transanal total mesorectal excision in North America: initial assessment of a structured training program and the experience of delegate surgeons. Dis Colon Rectum 60:1023–31 [CrossRef] [PubMed] [Google Scholar]
  • Sylla P, Knol JJ, D’Andrea AP, et al (2020) Urethral injury and other urologic injuries during transanal total mesorectal excision. Ann Surg [epub ahead of print]. [Google Scholar]
  • Mege D, Hain E, Lakkis Z, et al (2018) Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal Dis 20:O314–O151 [Google Scholar]
  • Dickson EA, Penna M, Cunningham C, et al (2019) Carbon dioxide embolism associated with total mesorectal excision surgery. Dis Colon Rectum 62:794–801 [CrossRef] [PubMed] [Google Scholar]
  • Koedam TWA, Veltcamp Helbach M, van de Ven PM, et al (2018) Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. Tech Coloproctol 22:279–87 [Google Scholar]
  • Lelong B, de Chaisemartin C, Meillat H, et al (2017) A multicentre randomized controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAPGRECCAR 11 TRIAL): rationale and design. BMC Cancer 17:1–8 [CrossRef] [PubMed] [Google Scholar]
  • Deijen CL, Velthuis S, Tsai A, et al (2016) COLOR III: a multicentre randomized clinical trial comparing transanal TME versus laparoscopic TME for mid- and low-rectal cancer. Surg Endosc 30:3210–15 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.